SARS-CoV-2 enzyme NendoU
From Proteopedia
(Difference between revisions)
| (6 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | <SX viewer='molstar' load='' size='340' side='right' caption='' scene=''> | + | <SX viewer='molstar' load='6vww' size='340' side='right' caption='This is the structure of NendoU (PDB code [[6vww]]).' scene=''> |
| - | + | __TOC__ | |
== Function == | == Function == | ||
'''Uridylate-specific endoribonuclease (NendoU)''' | '''Uridylate-specific endoribonuclease (NendoU)''' | ||
| Line 7: | Line 7: | ||
The exact functional relevance of Nsp15 is currently unknown. Nsp15-deficient corona viruses remain viable and replicating <ref name="structure">PMID:32304108</ref>. However, conflicting studies have been published on Nsp15’s role in interfering with the innate immune response <ref>PMID:28484023</ref>,<ref>PMID:31351410</ref> and it has been suggested that Nsp15 degrades viral RNA as a method to hide it from host defences <ref name="structure" />. | The exact functional relevance of Nsp15 is currently unknown. Nsp15-deficient corona viruses remain viable and replicating <ref name="structure">PMID:32304108</ref>. However, conflicting studies have been published on Nsp15’s role in interfering with the innate immune response <ref>PMID:28484023</ref>,<ref>PMID:31351410</ref> and it has been suggested that Nsp15 degrades viral RNA as a method to hide it from host defences <ref name="structure" />. | ||
| - | |||
== Disease == | == Disease == | ||
| Line 24: | Line 23: | ||
SARS-CoV-2 Nsp15 from SARS-CoV-2 resembles previously observed endonucleases from SARS-CoV (0.52 Å RMSD, PDBID: 2H85) and MERS-CoV (1.16 Å RMSD, PDBID: 5YVD) <ref name="structure" />. | SARS-CoV-2 Nsp15 from SARS-CoV-2 resembles previously observed endonucleases from SARS-CoV (0.52 Å RMSD, PDBID: 2H85) and MERS-CoV (1.16 Å RMSD, PDBID: 5YVD) <ref name="structure" />. | ||
| - | |||
== See also == | == See also == | ||
[[Coronavirus_Disease 2019 (COVID-19)]] | [[Coronavirus_Disease 2019 (COVID-19)]] | ||
| + | |||
| + | ==3D structures of uridylate-specific endoribonuclease== | ||
| + | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
| + | |||
| + | [[6vww]], [[6w01]], [[6xdh]], [[7k9p]], [[7keg]], [[7keh]], [[7kf4]] – SCv2NendoU – SARS-CoV-2 <br /> | ||
| + | [[2ozk]], [[2rhb]], [[4rs4]], [[4s1t]] – SCv2NendoU (mutant)<br /> | ||
| + | [[6wlc]], [[6x4i]], [[7k0r]], [[7k1l]], [[7k1o]] – SCv2NendoU + uridine derivative<br /> | ||
| + | [[5s6y]], [[5s72]] – SCv2NendoU + urea derivative<br /> | ||
| + | [[5s71]] – SCv2NendoU + thiothymidine<br /> | ||
| + | [[5s6x]], [[5s6z]], [[5s70]] – SCv2NendoU + imidazole derivative<br /> | ||
| + | [[6wxc]] – SCv2NendoU + drug<br /> | ||
| + | [[6x1b]] – SCv2NendoU + DNA<br /> | ||
| + | [[5yvd]] – NendoU – MERS coronavirus<br /> | ||
__NOTOC__ | __NOTOC__ | ||
</SX> | </SX> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Current revision
| |||||||||
References
- ↑ Ulferts R, Ziebuhr J. Nidovirus ribonucleases: Structures and functions in viral replication. RNA Biol. 2011 Mar-Apr;8(2):295-304. doi: 10.4161/rna.8.2.15196. Epub 2011 Mar 1. PMID:21422822 doi:http://dx.doi.org/10.4161/rna.8.2.15196
- ↑ 2.0 2.1 2.2 2.3 Kim Y, Jedrzejczak R, Maltseva NI, Wilamowski M, Endres M, Godzik A, Michalska K, Joachimiak A. Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2. Protein Sci. 2020 Apr 17. doi: 10.1002/pro.3873. PMID:32304108 doi:http://dx.doi.org/10.1002/pro.3873
- ↑ Deng X, Hackbart M, Mettelman RC, O'Brien A, Mielech AM, Yi G, Kao CC, Baker SC. Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages. Proc Natl Acad Sci U S A. 2017 May 23;114(21):E4251-E4260. doi:, 10.1073/pnas.1618310114. Epub 2017 May 8. PMID:28484023 doi:http://dx.doi.org/10.1073/pnas.1618310114
- ↑ Liu X, Fang P, Fang L, Hong Y, Zhu X, Wang D, Peng G, Xiao S. Porcine deltacoronavirus nsp15 antagonizes interferon-beta production independently of its endoribonuclease activity. Mol Immunol. 2019 Oct;114:100-107. doi: 10.1016/j.molimm.2019.07.003. Epub 2019, Jul 24. PMID:31351410 doi:http://dx.doi.org/10.1016/j.molimm.2019.07.003
